DSGN logo

DSGN

Profile

Full Name

Design Therapeutics, Inc.

Ticker Symbol

NASDAQ: DSGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 29, 2021

Indexes

Not included

Website

http://www.designtx.com

Employees

56

Key Details

Price

$3.77(+2.45%)

Market cap

$214.02M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.88(+26.05% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.77
    DSGN price is $3.77

    30-Day Relative Volume

    0.50
    DSGN 30-day relative volume is 0.50

    Price Performance

    Price Most recent change

    +2.45%
    DSGN price was up +2.45% on Jul 3, 2025

    Price YTD change

    -38.9%
    DSGN price is down -38.9% since January 1st

    Price 1-year change

    +18.18%
    DSGN price is up +18.18% year-on-year

    Price 3-year change

    -73.24%
    DSGN price is down -73.24% over the past 3 years

    Price Range

    Price All-time high

    $43.00
    DSGN price is currently -91.23% below its historical high of $43.00

    Price 3-year low

    $1.94
    DSGN price is currently +94.33% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $214.02M
    DSGN market capitalization is $214.02 million

    Market cap 3-year change

    -72.74%
    DSGN market capitalization is down -72.74% over the past 3 years

    Market cap All-time high

    $1.83B
    DSGN market capitalization is currently -88.31% below its historical high of $1.83 billion

    Market cap sector rank

    54.06%
    DSGN market capitalization is higher than 54.06% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.26%
    DSGN shares outstanding is up +0.26% year-on-year

    Shares Outstanding 3-Year Change

    +1.89%
    DSGN shares outstanding is up +1.89% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.01
    DSGN beta is 1.01

    200-day SMA

    $4.80
    DSGN price is currently -21.51% below its 200-day simple moving average

    50-day SMA

    $3.86
    DSGN price is currently -2.29% below its 50-day simple moving average

    RSI

    49.65
    DSGN 14-day relative strength index is 49.65

    Volume

    0.50
    DSGN 30-day relative volume is 0.50

    ATR

    $0.26
    DSGN average true range is $0.26

    10-day Historical Volatility

    65.87%
    DSGN 10-day historical volatility is 65.87%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    DSGN annual revenue value is unknown

    Revenue Analysts estimate

    -
    DSGN annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    DSGN annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    DSGN annual revenue is unknown

    EPS

    EPS

    -$0.88
    DSGN annual earnings per share is -$0.88

    EPS Analysts estimate

    -$1.33
    DSGN annual earnings per share is currently -33.83% lower than the consensus analysts' forecast

    EPS 1-year change

    +26.05%
    DSGN annual earnings per share is up +26.05% year-on-year

    EPS Sector rank

    59.11%
    DSGN annual earnings per share is higher than 59.11% of companies in Healthcare sector

    Profit

    Gross profit

    -
    DSGN annual gross profit value is unknown

    Gross margin

    -
    DSGN annual gross profit margin value is unknown

    Operating profit

    -$62.38M
    DSGN annual operating income is -$62.38 million

    Operating margin

    -
    DSGN annual operating profit margin value is unknown

    Net income

    -$49.59M
    DSGN annual net profit is -$49.59 million

    Net margin

    -
    DSGN annual net profit margin value is unknown

    Expenses

    Total expenses

    $62.38M
    DSGN annual total expenses is $62.38 million

    Operating expenses

    $62.38M
    DSGN annual total operating expenses is $62.38 million

    Cost of goods sold

    -
    DSGN annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $18.03M
    DSGN annual SGA is $18.03 million

    Depreciation and amortization

    $596.00K
    DSGN annual depreciation & amortization is $596.00 thousand

    Interest expense

    -
    DSGN annual interest expense value is unknown

    Income tax

    -
    DSGN annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$62.38M
    DSGN annual earnings before interest & taxes is -$62.38 million

    EBITDA

    -$61.79M
    DSGN annual EBITDA is -$61.79 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $252.09M
    DSGN annual total assets is $252.09 million

    Non current assets

    $4.05M
    DSGN annual long term assets is $4.05 million

    Current assets

    $248.04M
    DSGN annual total current assets is $248.04 million

    Cash and cash equivalents

    $22.56M
    DSGN annual cash & cash equivalents is $22.56 million

    Accounts receivable

    -
    DSGN annual accounts receivable value is unknown

    Inventory

    -
    DSGN annual inventory value is unknown

    Liabilities

    Total liabilities

    $10.00M
    DSGN annual total liabilities is $10.00 million

    Long term liabilities

    $1.53M
    DSGN annual total long term liabilities is $1.53 million

    Current liabilities

    $8.46M
    DSGN annual total current liabilities is $8.46 million

    Accounts payable

    $2.19M
    DSGN annual accounts payable is $2.19 million

    Debt

    Total debt

    $2.33M
    DSGN annual total debt is $2.33 million

    Total debt 1-year change

    -23.48%
    DSGN annual total debt is down -23.48% year-on-year

    Long term debt

    $1.53M
    DSGN annual long term debt is $1.53 million

    Short term debt

    $800.00K
    DSGN annual short term debt is $800.00 thousand

    Equity & Capital

    Shareholders equity

    $242.10M
    DSGN annual stockholders equity is $242.10 million

    Book value

    $242.10M
    DSGN annual book value is $242.10 million

    Retained earnings

    -$227.21M
    DSGN annual retained earnings is -$227.21 million

    Working capital

    $239.58M
    DSGN annual working capital is $239.58 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$43.10M
    DSGN annual cash flow from operations is -$43.10 million

    Cash from operations 1-year change

    +26.39%
    DSGN annual cash flow from operations is up +26.39% year-on-year

    Cash from investing

    $43.95M
    DSGN annual cash flow from investing activities is $43.95 million

    Cash from investing 1-year change

    -16.33%
    DSGN annual cash flow from investing activities is down -16.33% year-on-year

    Cash from financing

    $513.00K
    DSGN annual cash flow from financing activities is $513.00 thousand

    Cash from financing 1-year change

    -29.14%
    DSGN annual cash flow from financing activities is down -29.14% year-on-year

    CAPEX

    CAPEX

    -
    DSGN annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    DSGN annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$43.45M
    DSGN annual free cash flow is -$43.45 million

    Free cash flow 1-year change

    +26.13%
    DSGN annual free cash flow is up +26.13% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DSGN annual gross profit margin value is unknown

    Operating margin

    -
    DSGN annual operating profit margin value is unknown

    Net margin

    -
    DSGN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -19.67%
    DSGN annual return on assets is -19.67%

    ROE

    -20.48%
    DSGN annual return on equity is -20.48%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DSGN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DSGN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.94
    DSGN price to book ratio is 0.94

    PB ratio Sector rank

    38.51%
    DSGN price to book ratio is higher than 38.51% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    DSGN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    DSGN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $202.49M
    DSGN enterprise value is $202.49 million

    Enterprise value Sector rank

    55%
    DSGN enterprise value is higher than 55% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.99
    DSGN EV/EBITDA is -2.99

    EV/EBITDA Sector rank

    31.97%
    DSGN EV/EBITDA is higher than 31.97% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    29.31
    DSGN annual current ratio is 29.31

    Quick ratio

    -
    DSGN annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.01
    DSGN annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    DSGN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DSGN piotroski f-score value is unknown

    Altman Z-Score

    -
    DSGN altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Aug 6, 24 RBC Capital
    Sector Perform
    May 7, 24 Piper Sandler
    Overweight
    Mar 20, 24 Wedbush
    Neutral
    Mar 20, 24 RBC Capital
    Sector Perform
    Nov 14, 23 RBC Capital
    Sector Perform
    Aug 15, 23 Wedbush
    Neutral
    Aug 15, 23 SVB Leerink
    Market Perform
    Aug 15, 23 RBC Capital
    Sector Perform
    May 10, 23 Wedbush
    Outperform
    May 10, 23 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with DSGN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Design Therapeutics, Inc.?
    • Does Design Therapeutics, Inc. pay dividends?
    • What sector is Design Therapeutics, Inc. in?
    • What industry is Design Therapeutics, Inc. in?
    • What country is Design Therapeutics, Inc. based in?
    • When did Design Therapeutics, Inc. go public?
    • Is Design Therapeutics, Inc. in the S&P 500?
    • Is Design Therapeutics, Inc. in the NASDAQ 100?
    • Is Design Therapeutics, Inc. in the Dow Jones?
    • When was Design Therapeutics, Inc.'s last earnings report?
    • When does Design Therapeutics, Inc. report earnings?

    What is the ticker symbol for Design Therapeutics, Inc.?

    The ticker symbol for Design Therapeutics, Inc. is NASDAQ:DSGN

    Does Design Therapeutics, Inc. pay dividends?

    No, Design Therapeutics, Inc. does not pay dividends

    What sector is Design Therapeutics, Inc. in?

    Design Therapeutics, Inc. is in the Healthcare sector

    What industry is Design Therapeutics, Inc. in?

    Design Therapeutics, Inc. is in the Biotechnology industry

    What country is Design Therapeutics, Inc. based in?

    Design Therapeutics, Inc. is headquartered in United States

    When did Design Therapeutics, Inc. go public?

    Design Therapeutics, Inc.'s initial public offering (IPO) was on March 29, 2021

    Is Design Therapeutics, Inc. in the S&P 500?

    No, Design Therapeutics, Inc. is not included in the S&P 500 index

    Is Design Therapeutics, Inc. in the NASDAQ 100?

    No, Design Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Design Therapeutics, Inc. in the Dow Jones?

    No, Design Therapeutics, Inc. is not included in the Dow Jones index

    When was Design Therapeutics, Inc.'s last earnings report?

    Design Therapeutics, Inc.'s most recent earnings report was on May 7, 2025

    When does Design Therapeutics, Inc. report earnings?

    The next expected earnings date for Design Therapeutics, Inc. is August 5, 2025
    On this page